of FDA-approved medications do not provide the optimal outcome.
is wasted annually on suboptimal and adverse medication outcomes.
response rate of some of the best selling medications in history.
Our tests redefine the boundaries of precision medicine by allowing objective prediction of drug response, prior to initiating therapy.
From discovery to test development in months.
Biomarker tests with sensitivity and specificity well above 90%.
Using AI-based technology that can solve complex issues across all disease states.
Our strategic partnerships are quintessential to our success. With decades of experience and hundreds of projects successfully developed, we have minimized any potential for error while expediting the development process.